Chart calendar Cardiol Therapeutics Inc.

f278fd372e90eac54c3ded69d4bb.myU1QxcJ54WDX52FaGpRhGUllYs5XTkEfqNWapUAUe8.yXdCDXRNlNDcBfjiAg1ktg1X4PgAF1tbHOBhG9gwaZjjR3gsIDCpzvo08g~25d8090be04355bec77362b59faada9f

Upcoming events on Cardiol Therapeutics Inc.

No events available

Past events on Cardiol Therapeutics Inc.

25/06/2026

Annual General Meeting

06:30 am
25/06/2026

Présentation aux Actionnaires / Analystes

06:30 am
19/05/2026

Information meeting

15/05/2026

Information meeting

02:00 am
15/04/2026

Information meeting

02:00 am
02/12/2025

Information meeting

12:30 am

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million CAD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


2,00


65,9

EBITDA
Million CAD
Released
Forecast
Spread
-29,5
-26,8
-10.27%
-40,1
-35,5
-12.85%
-34,2
-33,8
-1.09%

-35,9


-20,3


-20,6

EBIT
Million CAD
Released
Forecast
Spread
-29,8
-28,5
-4.51%
-40,3
-38,2
-5.41%
-34,3
-35,6
3.54%

-38,1


-37,7


-8,01

Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
-28,1
-28,1
-0.28%
-36,7
-37,6
2.39%
-33,8
-35,9
5.86%

-41,4


-37,7


-7,83

Net income
Million CAD
Released
Forecast
Spread
-28,1
-28,1
-0.28%
-36,7
-37,6
2.39%
-33,8
-35,9
5.86%

-41,4


-37,7


-8,36

EPS
CAD
Released
Forecast
Spread
-0,44
-0,44
-1.15%
-0,51
-0,53
3.77%
-0,39
-0,43
8.24%

-0,36


-0,31


-0,08

Announcement Date01/04/2431/03/2531/03/26-

Quarterly results

Fiscal PeriodSeptember 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million CAD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million CAD
Released
Forecast
Spread
-8,43
-10,5
19.72%
-7,68
-10,1
24%
-10,2
-8,63
-17.92%
-8,03
-9,80
18.05%
-9,71
-8,47
-14.65%
-7,94
-9,97
20.36%
-9,80
-9,19
-6.66%

-10,6


-9,70


-10,5


-11,9


-11,5

Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
-8,29
-9,95
16.71%
-8,35
-9,73
14.17%
-9,96
-8,27
-20.54%
-7,21
-8,53
15.48%
-10,8
-8,40
-28.79%
-6,08
-9,87
38.36%
-13,3
-9,08
-46.79%

-11,2


-9,70


-10,5


-11,9


-11,5

Net income
Million CAD
Released
Forecast
Spread
-8,29
-9,95
16.71%
-8,35
-9,73
14.17%
-9,96
-8,27
-20.54%
-7,21
-8,53
15.48%
-10,8
-8,40
-28.79%
-6,08
-9,87
38.36%
-13,3
-9,08
-46.79%

-11,2


-9,70


-10,5


-11,9


-11,5

EPS
CAD
Released
Forecast
Spread
-0,10
-0,14
25.93%
-0,10
-0,12
18.92%
-0,12
-0,10
-20%
-0,07
-0,10
30%
-0,10
-0,09
-11.11%
-0,05
-0,10
48.28%
-0,11
-0,08
-44.11%

-0,09


-0,08


-0,08


-0,08


-0,07

Announcement Date14/05/2514/08/2513/11/2531/03/2611/05/2612/08/2612/11/26-----
18/11/2026

Annual General Meeting

24/11/2026

Earnings presentation

06:00 pm
24/11/2026

Earnings release - Q3 2026

25/11/2026

Earnings release - Q3 2026

25/11/2026

Earnings presentation

01:00 am
26/11/2026

Analyst/Investor Day

07:30 pm
01/12/2026

Extraordinary General Meeting

01/12/2026

Présentation aux Actionnaires / Analystes

10:00 am
01/12/2026

Extraordinary General Meeting

12:00 pm
02/12/2026

Analyst/Investor Day

01:00 am

Past sector events for Cardiol Therapeutics Inc.

17/11/2026

Information meeting

04:30 am
17/11/2026

Information meeting

12:30 am
16/11/2026

Extraordinary General Meeting

12:30 pm
15/11/2026

Information meeting

12:00 am
14/11/2026

Analyst/Investor Day

12:30 am
13/11/2026

Earnings presentation

12:00 am
13/11/2026

Earnings release - Q3 2026

13/11/2026

Ex-dividend date - 0.08 USD

04:00 pm
13/11/2026

Analyst/Investor Day

12:00 am
13/11/2026

Earnings presentation

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cardiol Therapeutics Inc.

Quarterly earnings - Rate of surprise

Rate of surprise - EPS - Quarterly - Cardiol Therapeutics Inc.

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Cardiol Therapeutics Inc.

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Cardiol Therapeutics Inc.
  1. Stock Market
  2. Stocks
  3. CRDL Stock
  4. Calendar Cardiol Therapeutics Inc.